Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
|
|
|
|
Potential Breakthrough in the Search for New Treatment Options for Esophageal Cancer Patients
|
Kishore Guda, DVM, PhD, an associate professor of oncology at Case Western Reserve University School of Medicine, has been awarded $200,000 by The DeGregorio Family Foundation and the Price Family—partnering with the Savone Family and The Esophageal Cancer Awareness Association.
This award will support Dr. Guda's research at the Case Comprehensive Cancer Center on establishing a deeper understanding of the TGFbeta cellular pathway and its impact on the development of esophageal adenocarcinoma (EAC).
|
|
|
|
Chance Testifies Before US House on Synchrotron Facilities, Cancer-related Discoveries and Drug Development
|
Earlier this month,
Mark Chance, PhD, visited Washington DC to testify before the US House of Representatives Committee on Appropriations and report on synchrotron facilities at Case Western Reserve University (CWRU).
|
|
The
oversight hearing on the Department of Energy's role in advancing biomedical sciences, presented Dr. Chance alongside Narayanan 'Bobby' Kasthuri, MD, PhD of the Argonne National Laboratory and The University of Chicago and Harold Varmus, MD of Weill Cornell Medicine and former Director of the National Institutes of Health and National Cancer Institute.
Dr. Chance is Vice Dean for Research at the CWRU School of Medicine, Director of the Center for Proteomics and Bioinformatics and a member of the
Case Comprehensive Cancer Center (Case CCC) GI Cancer Genetics Program. In his testimony, which begins around
25:12 in the video above, he states simply, "DoE science facilities are critical to America's basic biomedical science, drug and device development, and public health goals of the nation with positive effects on the health and welfare of all Americans and saving many lives." Dr. Chance goes on to inform the Subcommittee on Energy and Water Development, and Related Agencies on the role of synchrotrons in drug development, where more than 90 percent of structures have the drug target solved at beamlines.
|
|
Work from Madabhushi's Group Featured in 2019 Research Highlights for the Epidemiology and Genomics Research Program
|
|
Join Team Case CCC in VeloSano 2020!
|
The Case Comprehensive Cancer Center (Case CCC) is honored to make its sixth appearance in
VeloSano, a year-round fundraising initiative and "Bike to Cure" weekend to support lifesaving cancer research. Our continuing goal is to bring sustainable funding to cancer research by enlisting the passion and energy of thousands of people who wish to give back... including
YOU! We raised nearly $94,000 in 2019 and every dollar goes directly toward cancer research. In our six years of participation, more than $1,000,000 of VeloSano fundraising totals have come back to the Case CCC to award researchers as pilot funding for cancer research projects.
|
|
The Case CCC will provide complimentary registration fees and jerseys again this year. Contact team captains
Caroline El Sanadi or
Mary Wright for the registration fee waiver code to sign up! While registration is complimentary, all riders are responsible for meeting the minimum fundraising commitment associated with the
distance they ride. Fundraising can begin as soon as you register to ride and continues through October 1, 2020.
Registration is open now and information about volunteering for our cheer station and supporting our team through sponsorship will be available soon!
|
|
Mon, Feb 17
Genomic Medicine Institute Seminar
12p NE1-205
Wolstein Research Building Faculty Meetings with Stan Gerson
3:30p WRB
|
|
Tues, Feb 18
Dept of Pathology Seminar
Mark Jackson, PhD
12p WRB Auditorium
Cancer Drug Discovery and Resistance
3p WRB 1-422D
Pavey Family Designated Professorship Ceremony
Mark Griswold, PhD
4:30p WRB
|
|
Weds, Feb 19
Biomedical Innovation and Entrepreneur Club
4-6p BRB 932
|
|
Thurs, Feb 20
D
evelopmental Therapeutics Journal Club
9a NE6-218
Molecular Biology and Microbiology Seminar
1p SOM W203
Reception Celebrating Monica Webb Hooper, PhD
4-6p WRB Rear Lobby
|
|
Fri, Feb 21
Taussig Cancer Institute Grand Rounds
8a CA5-120
Cancer Center Seminar Series
David Chambers, DPhil
12p WRB Auditorium
|
|
|
Mon, Feb 24
BME Guest Seminar
Gertraud Orend, PhD
11a NC1-202
Cancer Center Research Chalk Talk
1p WRB 3-136
|
|
Tues, Feb 25
DNA Damage and Repair Working Group
3p NB5-09
|
|
Thurs, Feb 27
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
12p WRB 5-136
Molecular Biology and Microbiology Seminar
1p SOM W203
|
|
Fri, Feb 28
Taussig Cancer Institute Grand Rounds - CCF Only
8a CA5-120
Cancer Center Seminar Series
Sudha Chakrapani, PhD
12p WRB Auditorium
|
|
|
 |
Cancer Center Seminar Series
February 14, 12p
WRB Auditorium
Our weekly seminar series features
Jan Grimm, MD, PhD at noon today in the auditorium of the Wolstein Research Building.
Dr. Grimm is Associate Attending at Memorial Hospital, Associate Professor, Cornell Radiology and Gerstner Graduate School of Biomedical Sciences, and Associate Member of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center.
He will present, "Imaging with the Speed of Sound and Light" on behalf of the Cancer Imaging Program.
|
|
|
|
Cancer Center Seminar Series
February 21, 12p
WRB Auditorium
Next week's cancer center seminar will be presented by
David Chambers, DPhil on behalf of the Cancer Imaging Program.
Dr. Chambers is Deputy Director for Implementation Science at the National Cancer Institute, National Institutes of Health.
He will present, "Advancing the Science of Implementation in Cancer: An NCI Perspective" at noon in the WRB Auditorium.
|
|
|
|
|
Pavey Family Designated Professorship Ceremony
February 18, 4:30p
Wolstein Research Building
Join President Barbara R. Snyder to celebrate the generosity of the Pavey Family and the appointment of
Mark Griswold, PhD as the Pavey Family Designated Professor of Innovative Imaging - Revolutionizing the Worlds of Education and Medicine.
A ceremony will take place on Tuesday, February 18 at 4:30 pm in the Wolstein Research Building with a reception to follow. Dress is business attire and complimentary valet parking will be available off of Circle Drive.
|
|
|
|
Farewell Reception for Monica Webb Hooper, PhD
February 20, 4-6p
Wolstein Research Building Rear Lobby
Join us on Thursday, February 20 for a farewell reception celebrating
Monica Webb Hooper, PhD, Case Comprehensive Cancer Center Associate Director for Cancer Disparities Research, and
her appointment as Deputy Director of the National Institute on Minority Health and Health Disparities.
|
|
|
|
|
3 Weeks Away: 4th Annual Cancer Disparities Symposium
March 6, 2020
Tinkham Veale University Center, CWRU
The
4th Annual Cancer Disparities Symposium
: Cultivating Science and Community Engagement to Address Cancer Health Disparities is less than one month away! Don't miss the opportunity to join researchers, physicians, and community leaders as we share cutting edge science and innovations in community engagement.
The
symposium agenda is now posted and features sessions on Cancer Disparities and Underserved Populations, such as sexual and gender minorities, Amish, and muslim women, Community Engagement and Support Programs, and Cancer Disparities Research and Community Engagement, plus invited presentations selected from standout abstract submissions. The final session of the day will be a multidisciplinary and thought-provoking panel discussion that will crystallize the energy and inspire us to continue toward the ultimate goal of health equity.
Robert T. Croyle, PhD of the National Cancer Institute will deliver the day's Plenary Address and and
Lucio Miele, MD, PhD from Louisiana State University is this year's Distinguished Scientific Keynote speaker.
Attendees are eligible to receive six (6) continuing research education credits (CRECs) or six (6) continuing education contact hours (CECH) units of advanced level training in health education. Meals, materials, refreshments and parking will be provided.
|
|
|
|
Research ShowCASE 2020
April 17, 9a-3p
Veale Convocation Center
CWRU faculty, staff and students by presenting your work at
Research ShowCASE 2020. The event will provide an opportunity for CWRU researchers to display your research in a traditional scientific poster or other creative means. We encourage University Hospitals, Cleveland Clinic, MetroHealth Medical Center and the Louis Stokes Cleveland VA Medical Center researchers to participate.
In addition to the opportunity to display and share your work, undergraduate and graduate students, professional students and postdoctoral scholars are encouraged to participate in the research competition, which will include having your presentation evaluated and feedback provided. Cash prizes will be awarded to winning entries.
In order to display your work at
Research ShowCASE, you will need to submit an online abstract describing your research. If you are a student or post-doc, your faculty adviser will need to approve your submission.
Abstract Deadlines:
Graduate and professional students, post-docs, faculty, staff and affiliates: February 16, 2020
Undergraduate and high school students: March 20, 2020
|
|
|
|
|
Registration Opening Soon: Cancer Stem Cell Conference 2020
August 4-6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center and the National Center for Regenerative Medicine invite you to save the date for CSC 2020!
Now in its fourth year, CSC 2020 will feature renowned thought leaders in the field of cancer stem cell research. This conference is guaranteed to offer cutting-edge keynote presentations from a variety of niches within the field. Join world-class investigators for this three-day summit and network with scientists and clinicians advancing cancer stem cell research and therapeutic applications.
Registration and abstract submission will open soon!
|
|
|
|
Save The Date: Great Lakes Breast Cancer Symposium 2020
October 4-6, 2020
Tinkham Veale University Center, CWRU
As host site for the 2020 Great Lakes Breast Cancer Symposium, the Case Comprehensive Cancer Center encourages you to mark your calendar for the symposium taking place October 4-6, 2020.
The symposium highlights ongoing basic, translational, clinical and population studies addressing the biological mechanisms, management and prevention of breast cancer. Researchers from participating institutions will share their exciting work with a goal to develop cross-institutional collaborations.
This year's event features two keynote speakers:
- Carlos Arteaga, MD, Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center
- Helen Piwnica-Worms, PhD, Professor of Experimental Radiation Oncology at the University of Texas MD Anderson Cancer Center
|
|
|
|
Additional Upcoming Events
|
|
|
Management of Checkpoint Inhibitor-Related Toxicity Conference
March 6, 2020
InterContinental, Cleveland
|
Immune checkpoint blockade leads to a new spectrum of dysimmune toxicity requiring collaboration between oncologists, providers, and specialists to improve the understanding of the mechanism, diagnosis, and management of immune-related adverse events (irAEs). The goal of this conference is to bring together a multidisciplinary group of clinicians to share expertise and improve the care of patients receiving immune checkpoint inhibitor therapies.
|
|
|
|
NCCN 2020 Annual Conference
March 20-22, 2020
Orlando, FL
The National Comprehensive Cancer Network (NCCN) 2020 Annual Conference agenda includes 30 educational sessions featuring the latest advances in oncology care, including interactive patient case studies. Session topics include: HPV-Associated Cancers, Patient-Reported Outcomes, Clinical Trial Implementation, Value-Based Payment Models, Role of Biosimilars and more.
|
|
|
|
|
AACR Annual Meeting
April 24-29, 2020
San Diego Convention Center
|
The American Association for Cancer Research (AACR) Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.
This year's meeting will take place April 24-29, 2020 at the San Diego Convention Center in San Diego, CA.
Final data for clinical abstract placeholders is due Thursday, February 20.
|
|
|
|
2020 NIMHD Health Disparities Research Institute
August 3-7, 2020
NIH Campus, Bethesda, MD
|
The National Institute on Minority Health and Health Disparities (NIMHD) will host the Health Disparities Research Institute (HDRI) from August 3-7, 2020 at the NIH campus (Natcher, Building 45 conference center rooms). The HDRI aims to support the research career development of promising early-career minority health and health disparities research scientists and stimulate research in disciplines supported by health disparities science. Applications will only be accepted from extramural scientists who meet NIH’s
Early Stage Investigator (ESI) eligibility criteria.
The program will feature lectures, mock grant reviews, seminars, and small group discussions on research relevant to minority health and health disparities. It will also include sessions with NIH scientific staff engaged in related health disparities research across the various institutes and centers.
Extramural scientists, early in their careers with research foci in minority health and health disparities, are encouraged to apply to the institute.
Applications are now open and must be submitted via the HDRI application portal by
Monday, March 9, 2020 at 5pm EST; emailed applications will not be accepted. Applicants are encouraged to apply before the deadline since late submissions will not be accepted. Questions may be directed to
HDRI@nih.gov.
|
|
|
|
LOI Deadline: March 16, 2020
The Case Comprehensive Cancer Center, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine, University Hospitals of Cleveland and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges affiliated with Case Western Reserve University are eligible. Grants, not to exceed $40,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
Award Description
- Pilot funding for CANCER-RELATED research with a basic, clinical, prevention and control, behavioral, health services or epidemiological focus.
- Up to $40,000 award.
- Applications accepted for general cancer-related projects and for special interest projects in adolescent-and-young-adult cancer research.
|
|
Leapsmag - Jan 31, 2020
University Hospitals urologist
Lee Ponsky, MD says a combined MRI and computerized tool would be, "the closest to a crystal ball that we can get" in detecting and grading prostate cancer.
Anant Madabhushi, MS, PhD, director of the Center for Computational Imaging and Personalized Diagnostics at CWRU also weighs in. Both Dr. Ponsky and Dr. Madabhushi are members of the
Case CCC.
|
|
ASCO Post - Feb 10, 2020
"We investigate how to use computer algorithms to interrogate the radiographic and pathology images to tease out the features and backgrounds the human eye may not be able to visually appreciate," said
Anant Madabhushi, MS, PhD at the ASCO Breakthrough Global Summit in October 2019.
|
|
Weekly NIH Funding Opportunities and Notices
|
Notices
Funding Opportunities
Deadline: April 14, 2020
|
|
Use the button below to submit all your news, events, announcements and communications requests to the Case CCC Marketing and Communications team!
|
|
|
|
|
|
|
